Back to Startups

The EVERY Company

About The EVERY Company

A biotechnology firm advancing precision-fermented, highly functional proteins, specializing in animal-free egg proteins.

Business Information
Target Customers
food manufacturers restaurants consumers
Industry Categories
Bioscience & Disease Food, Restaurants, Groceries Sustainability
Business Model
Revenue Model B2B sales of protein ingredients
Pricing Strategy Custom pricing based on volume and application
Sales Channels direct sales, partnerships with food manufacturers
Funding Timeline
Round Date Amount Investors
Series D Nov 05, 2025 $55.0M McWin Capital Partners, Main Sequence, Bloom8 +3 more
Founders

No founder information available.

Investors
B
Bloom8

Venture Capital

G
Grosvenor

Alternative Investment Manager

M
Main Sequence

Venture Capital

M
McWin Capital Partners

Venture Capital

M
McWin Capital Partners

Venture Capital

M
Minerva Foods

Corporate

Recent Mentions
TradedVC
Traded: Venture Capital @TradedVC
Nov 05, 2025

The EVERY Company, a San Francisco–based biotechnology firm advancing precision-fermented, highly functional proteins, has closed a $55M Series D round led by McWin Capital Partners, with participation from Main Sequence, Bloom8, https://t.co/gAbFYFxgqu, Minerva Foods, Grosvenor https://t.co/cejmSisk1X

raisingfi
Raising.fi @raisingfi
Nov 05, 2025

New Raise 🏛️ Company: EVERY 🔗 Website: https://t.co/K8nfZzBwmY 📊 Amount: $55 Million 🔄 Round: Series D 🧮 Valuation: N/A ⚙️ Industry: Biotechnology, Food & Agriculture

drewfallon12
Drew Fallon @drewfallon12
Nov 06, 2025

WEEKLY CPG TRANSACTION ROUNDUP 11.6.25 VC Deals: - The Every Company, producer of animal-free egg proteins raises $55M Series D bringing total funding to $294M. The round was led by McWin Capital Partners. - Cymbiotika, the wellness brand behind viral liposomal supplements https://t.co/YqHzmnRJz2